Kezar Life Sciences raises $75M in slightly upsized IPO
June 21, 2018 at 10:07 AM EDT
The South San Francisco biotech sold 5 million shares at $15. It was expected to sell 4.7 million shares for between $14 and $16.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.